Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Cyst Fibros. 2020 Jun 7;19(5):677–687. doi: 10.1016/j.jcf.2020.05.011

Figure 1 – CF Therapeutics Drug Pipeline.

Figure 1 –

Reproduced with permission of the US Cystic Fibrosis Foundation, Bethesda, Maryland. Copyright © March 18, 2020 by the US Cystic Fibrosis Foundation. The pipeline includes any new therapies that are either being funded by the Cystic Fibrosis Foundation ($US2 million or more in support) or being tested by clinical trials in the Cystic Fibrosis Foundation Therapeutics Development Network. Therapies at the end of phase 3 completion or indicated as available to patients represent status within the United States, which may notably differ from global access and availability.